Biomedical literature, made navigable
Discover articles through diseases, drugs, treatments, interventions, clinical instruments, institutions and funders extracted from the BMJ open corpus.
An entity family is a category of extracted information. Choose one to browse its named entities and supporting articles.
Organisations named as supporting, sponsoring, or funding research.
5,089 articles · 9,137 mentionsInstitutionsUniversities, hospitals, research centres, networks, and public bodies.
11,350 articles · 22,378 mentionsDrugsNamed medicines, compounds, vaccines, and pharmacological agents.
10,506 articles · 58,393 mentionsDiseasesNamed diseases, disorders, syndromes, injuries, and health conditions.
23,712 articles · 125,551 mentionsTreatmentsClinical therapies and care approaches used to manage a condition.
7,227 articles · 16,644 mentionsInterventionsProgrammes, procedures, policies, and other actions being evaluated.
4,132 articles · 9,994 mentionsClinical instrumentsNamed questionnaires, scales, scores, indices, and other clinical outcome assessments.
945 articles · 1,957 mentionsChoose an entity to see the articles in which it was identified.
…as conducted in US and similar trends were observed.Conclusions FL115 is the first IL-15 superagonist reporting PR as monotherapy in …
…rdination, the Abramson Cancer Center Microbiome Program at the University of Pennsylvania for sequencing and analytic support, and Dr. Benjamin Garcia an…
…measured by the normalised difference vegetation index (NDVI)): psychotic disorders, substance use disorders, mood disorders, behavioural disorders…
…nce for psilocybin, a Schedule I substance, in the treatment of chronic pain. The exact purpose of the review is to assess the impact of psi…
…de l’Université de Montréal (CHUM), a phase I clinical trial of KAN-004 in patients with irColitis is planned to begin in Q4 2025.…
…in J; CheckMate 067 Investigators. Final, 10-year outcomes with nivolumab plus ipilimumab in advanced melanoma. N Engl J Med. 2025;392(1)…
…Background Breast cancer is the most common cancer worldwide and triple negative breast …
…me countries (HICs) versus 0.67 in low-income countries (LICs); melanoma MIR dropped to 0.36 in HICs but remained elevated at 0.87 in LI…
…th the immune cold MOC2 cell line and found that treatment with AU-15330 significantly improved CD8+ T cell mediated killing.Conclusions…
…pan-tumor cutoff of 10 mutations (mt)/MB gained FDA approval of pembrolizumab although optimal cutoffs are not clearly defined. Here, we asse…
… dark matter elements shared with a dark matter cancer vaccine, DPV-001, administered as immunotherapy to patients with HNSCC and NSCLC…
…ated by an immunosuppressive myeloid infiltrate. Treatment with Cy/Flu depleted most circulating immune cells and TAMs. Cy/Flu plus IL…